Related Experiment Video
Updated: Jul 17, 2026
10:35
Stereotactic Radiosurgery for Gynecologic Cancer
Published on: April 17, 2012
18.2K
[Five-fraction radiotherapy for breast cancer]
M Dworczak1, G Bielinyte2, A Coutte3
1Département de radiothérapie, centre Oscar-Lambret, Lille, France.
Summary
Extreme hypofractionation in breast cancer radiotherapy is gaining attention. New projects explore treatment de-escalation and reduced side effects for better patient outcomes.
Area of Science:
- Oncology
- Radiotherapy
- Clinical Trials
Context:
- Extreme hypofractionation is a rapidly evolving area in adjuvant breast radiotherapy.
- Current interest focuses on optimizing treatment delivery and patient outcomes.
Purpose:
- To synthesize existing hypofractionation trials.
- To present the DESTHE COL and DESTHE GR projects.
- To experiment with care pathways for therapeutic de-escalation and reduced sequelae.
Summary:
- The study reviews hypofractionation trials in breast cancer radiotherapy.
- It introduces the DESTHE COL and DESTHE GR projects, supported by the French National Cancer Institute (INCa).
- These projects aim to implement strategies for de-escalating treatment and minimizing long-term side effects.
Impact:
- Provides a comprehensive overview of hypofractionation research.
- Offers insights into innovative care pathways for breast cancer treatment.
- Contributes to the development of evidence-based strategies for reducing treatment burden and improving quality of life for cancer survivors.
Related Concept Videos
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...